AML MRD Flow Panel

Submitted by Anonymous (not verified) on
Code
FLG-AMLX-03BX
Panel
Active-Compendium
88184x1, 88185x19. Add 88189x1 for Global
Clinical
Oncology,Pathology
Bone marrow aspirate: 2-3 mL, first pull.  EDTA preferred. Sodium heparin tube acceptable. Lithium heparin or ACD (pale yellow/no gel separator) not acceptable. Please provide recent CBC report.
Hematologic Diseases
Acute myeloid leukemia (AML)
Flow Cytometry
Global
Flag Active
True
Orderable Test Description
<p>Available as Global test only. Markers are CD7, CD11b, CD13, CD14, CD15, CD16, CD19, CD2, CD33, CD34, CD38, CD4, CD45, CD56, CD64, CD65, CD87, CD117, CD371, HLA-DR (20 markers). This panel can detect MRD at the 0.01% level.</p>
Orderable Turn Around Time
1 Day
Keywords
acute myeloid leukemia flow
AML MRD
aml minimal residual disease
AML flow
AML
Meta Description
<p>MRD assessment has the potential to improve outcomes for patients with acute myeloid leukemia (AML).</p>
Extra Note

Use cold pack for transport, making sure cold pack is not in direct contact with specimen. Lithium heparin or ACD (pale yellow/no gel separator) is not acceptable. Please provide recent CBC report.

Orderable Biomarkers
CD45
CD4
CD117
CD19
CD11b
CD34
CD13
CD14
CD16
CD33
CD64
HLA-DR
CD38
CD2
CD56
CD7
CD15
CD65
CD87
CD371
NY Approved
True
Orderable Biomarkers JSON
{"Flow Cytometry": {"Markers": ["CD45", "CD4", "CD117", "CD19", "CD11b", "CD34", "CD13", "CD14", "CD16", "CD33", "CD64", "HLA-DR", "CD38", "CD2", "CD56", "CD7", "CD15", "CD65", "CD87", "CD371"]}}
Keywords string
acute myeloid leukemia flow, AML MRD, aml minimal residual disease, AML flow, AML AML MRD Flow Panel
Title URL
aml-mrd-flow-panel